
Punjab MBBS students call off strike after govt agrees to address stipends & fee demands
The state government has yet to issue a statement confirming the development.
New Delhi: MBBS students and interns from various government medical colleges (GMCs) in three major cities in Punjab said they had called off a more than 50-day protest after the state government agreed to revise their stipends and review the fees. This came hours after the students announced a strike.
After a meeting between the Forum of Resident Doctors (FORD), Punjab, and state Health Minister Balbir Singh and Finance Minister Harpal Singh Cheema, which lasted over 5 hours, Dr. Milan, who was present at the meeting, said the government had agreed to address the students' concerns.
Under the revised stipend structure, junior doctors will receive Rs 76,000 in their first year, Rs 77,000 in their second year, and Rs 78,000 in their third year. Senior doctors, similarly, will receive Rs 92,000, Rs 93,000 and Rs 94,000 over their three years, a statement from FORD issued late Monday said.
The pay for interns was raised to Rs 22,000. These salaries would be reviewed yearly.
A MBBS Fees and Bond committee will review the fee hikes, the statement further said.
A notification in this regard is expected to be issued in two weeks.
In another statement, the FORD said, 'After detailed discussions, the Government of Punjab has agreed to constitute a committee to review and recommend reforms to make medical education fees more affordable. Additionally, the government has committed to a stipend hike for both MBBS and MD students, fulfilling a longstanding demand of resident doctors across the state.'
'In light of these significant developments, FORD Punjab has decided to call off the ongoing strike, and all OPD and hospital services will resume as normal from tomorrow, 1st July 2025.'
ThePrint reached out to the state health minister and Kumar Rahul, Punjab's principal secretary of health & family welfare, for comment through messages. This report will be updated if and when they respond.
ThePrint had earlier reported that discontent had been brewing since 2020, when the fee for the 5.5-year MBBS course (including one year compulsory internship) was hiked by a steep 77 percent in government colleges—from Rs 4.4 lakh to Rs 7.8 lakh. Since then, the state has continued to increase the fee by 5 percent annually.
Protesting interns argued that this placed an unsustainable financial burden on students, particularly those who were from economically weaker backgrounds. This was further compounded by the stagnant monthly stipend of Rs 15,000.
Punjab's stipend amount for interns is the lowest among neighbouring states: Haryana pays Rs 24,300 monthly, Himachal Pradesh Rs 20,000, Chandigarh Rs 30,070 and Delhi Rs 30,000.
Earlier, Kumar Rahul had acknowledged the issue, telling ThePrint on WhatsApp: 'There has been a 5 percent increase in fees every year since 2020. The protest is more about the demand for an increased stipend, which has been taken up with the Finance Department.'
On Monday, outpatient department (OPD) and operation theatre services were hit at GMCs in Amritsar, Faridkot and Patiala after the strike was announced.
A letter submitted by the Medical Students' Association to the director principal of GMC Amritsar, seen by ThePrint, said, 'Despite repeated representations and discussions, no concrete steps have been taken by the authorities to address these pressing issues. The stipend being paid is not in line with inflation, and the burden of bond-related fees has worsened the situation.'
'In view of the continued neglect of our demands, we have no option but to proceed with a strike.'
Similar letters were also submitted to authorities at GMCs in Faridkot and Patiala.
Speaking to ThePrint about the strike earlier, the president of the Medical Students' Association at GMC Amritsar and MBBS intern, Dr. Archit Bawa, said, 'It's been over 50 days now. Doctors of Punjab have been protesting on the roads, but our demands remain unaddressed. We didn't want to stop OPD services, but the government left us with no choice. This is our only resort.'
(Edited by Sanya Mathur)

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
an hour ago
- Time of India
Ludhiana's Punjab Agricultural University bags horticulture development research project.
Ludhiana: In a significant step toward promoting biocontrol of diseases, biocontrol laboratory, department of plant pathology, Punjab Agricultural University (PAU), has bagged MIDH (Mission for Integrated Development of Horticulture), Horticulture Mission Project, Government of Punjab, worth Rs 24 lakh. Scientists from the department of plant pathology, involved in the project, included principal investigator Dr Daljeet Singh Buttar; and Drs Amarjit Singh, (Mrs) Amrinder Kaur, Dr Ajay Chaudhary, and Dr Jagdish Arora. These scientists have brought laurels to the institution by bagging research project entitled 'Front line demonstration for management of foot rot/gummosis of citrus using biocontrol agent Trichoderma asperellum', awarded by MIDH for a duration of three years. The project will support research on biocontrol of citrus diseases at PAU. Dr Satbir Singh Gosal, PAU vice-chancellor, remarked, "This project is a testament to the outstanding research capabilities on biocontrol of diseases and dedication that exemplifies PAU's scientific community." Stay updated with the latest local news from your city on Times of India (TOI). Check upcoming bank holidays , public holidays , and current gold rates and silver prices in your area.


Economic Times
an hour ago
- Economic Times
Apollo Hospitals Enterprise shares surge over 6% after Q1 net profit rises 42%
Apollo Hospitals Enterprise shares surged 6.3% to 7,695 on Wednesday following the company's robust performance in the first quarter (Q1) of FY26. ADVERTISEMENT The healthcare giant reported a consolidated net profit of Rs 433 crore for Q1FY26, marking a significant 42% increase compared to Rs 305 crore in the same period last year. Sequentially, profit after tax (PAT) rose 11% from Rs 390 crore recorded in Q4FY25. Revenue from operations grew 15% year-on-year to Rs 5,842 crore in Q1FY26, up from Rs 5,086 crore in Q1FY25. On a sequential basis, the topline improved 4.5% compared to Rs 5,592 crore in Q4FY25. Healthcare services revenue came in at Rs 2,974 crore in Q1FY26, rising from Rs 2,843 crore in the previous quarter (Q4FY25) and Rs 2,654 crore in the same quarter last year (Q1FY25).Retail health & diagnostics revenue reached Rs 435 crore in Q1FY26, up from Rs 394 crore in Q4FY25 and Rs 366 crore in Q1FY25. ADVERTISEMENT Digital health & pharmacy distribution revenue stood at Rs 2,472 crore in Q1FY26, compared to Rs 2,376 crore in the previous quarter and Rs 2,082 crore in the year-ago period. Unlock 500+ Stock Recos on App The positive earnings and steady revenue growth across all business segments have boosted investor confidence, driving the stock price upward. ADVERTISEMENT The 14-day Relative Strength Index (RSI) for Apollo Hospitals Enterprise is currently at 47.5. Typically, an RSI below 30 indicates that a stock is oversold and may be undervalued, while an RSI above 70 suggests it is overbought and could be due for a correction. At 47.5, the stock is in a neutral zone, showing neither strong buying nor selling a moving averages perspective, Apollo Hospitals Enterprise is exhibiting a bullish trend as it is trading above all 8 key Simple Moving Averages (SMAs) — ranging from the short-term 5-day SMA to the long-term 200-day SMA. This consistent position above multiple SMAs suggests strong upward momentum and positive investor sentiment. ADVERTISEMENT (You can now subscribe to our ETMarkets WhatsApp channel)


Time of India
an hour ago
- Time of India
Apollo Hospitals Enterprise shares surge over 6% after Q1 net profit rises 42%
Apollo Hospitals Enterprise shares surged 6.3% to 7,695 on Wednesday following the company's robust performance in the first quarter (Q1) of FY26. The healthcare giant reported a consolidated net profit of Rs 433 crore for Q1FY26, marking a significant 42% increase compared to Rs 305 crore in the same period last year. Sequentially, profit after tax (PAT) rose 11% from Rs 390 crore recorded in Q4FY25. Revenue from operations grew 15% year-on-year to Rs 5,842 crore in Q1FY26, up from Rs 5,086 crore in Q1FY25. On a sequential basis, the topline improved 4.5% compared to Rs 5,592 crore in Q4FY25. Segment-wise revenue performance: Healthcare services revenue came in at Rs 2,974 crore in Q1FY26, rising from Rs 2,843 crore in the previous quarter (Q4FY25) and Rs 2,654 crore in the same quarter last year (Q1FY25). Retail health & diagnostics revenue reached Rs 435 crore in Q1FY26, up from Rs 394 crore in Q4FY25 and Rs 366 crore in Q1FY25. Digital health & pharmacy distribution revenue stood at Rs 2,472 crore in Q1FY26, compared to Rs 2,376 crore in the previous quarter and Rs 2,082 crore in the year-ago period. The positive earnings and steady revenue growth across all business segments have boosted investor confidence , driving the stock price upward. Technical Outlook The 14-day Relative Strength Index (RSI) for Apollo Hospitals Enterprise is currently at 47.5. Typically, an RSI below 30 indicates that a stock is oversold and may be undervalued, while an RSI above 70 suggests it is overbought and could be due for a correction. At 47.5, the stock is in a neutral zone, showing neither strong buying nor selling pressure. From a moving averages perspective, Apollo Hospitals Enterprise is exhibiting a bullish trend as it is trading above all 8 key Simple Moving Averages (SMAs) — ranging from the short-term 5-day SMA to the long-term 200-day SMA. This consistent position above multiple SMAs suggests strong upward momentum and positive investor sentiment.